Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Return on Invested Capital (2020 - 2025)

Historic Return on Invested Capital for Collegium Pharmaceutical (COLL) over the last 6 years, with Q3 2025 value amounting to 0.36%.

  • Collegium Pharmaceutical's Return on Invested Capital fell 300.0% to 0.36% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.36%, marking a year-over-year decrease of 300.0%. This contributed to the annual value of 0.22% for FY2024, which is 400.0% up from last year.
  • Latest data reveals that Collegium Pharmaceutical reported Return on Invested Capital of 0.36% as of Q3 2025, which was down 300.0% from 0.3% recorded in Q2 2025.
  • Collegium Pharmaceutical's Return on Invested Capital's 5-year high stood at 0.47% during Q2 2021, with a 5-year trough of 1.01% in Q4 2021.
  • Its 5-year average for Return on Invested Capital is 0.17%, with a median of 0.29% in 2023.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first tumbled by -11600bps in 2021, then soared by 10400bps in 2022.
  • Quarter analysis of 5 years shows Collegium Pharmaceutical's Return on Invested Capital stood at 1.01% in 2021, then skyrocketed by 104bps to 0.04% in 2022, then soared by 677bps to 0.29% in 2023, then surged by 41bps to 0.4% in 2024, then fell by -11bps to 0.36% in 2025.
  • Its Return on Invested Capital was 0.36% in Q3 2025, compared to 0.3% in Q2 2025 and 0.32% in Q1 2025.